| 2015 | A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2023 | Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer
| CANCER MEDICINE |
| 2016 | Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis | DISEASES OF THE COLON & RECTUM |
| 2016 | Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia | JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2011 | Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer | JOURNAL OF MAGNETIC RESONANCE IMAGING |
| 2017 | Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
| ONCOTARGET |
| 2016 | Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy
| ONCOTARGET |
| 2013 | Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineation | RADIOTHERAPY AND ONCOLOGY |
| 2023 | Effect of High-Versus Low-Frequency of Abdominopelvic Computed Tomography Follow-Up Testing on Overall Survival in Patients With Stage II Or III Colon Cancer | CLINICAL COLORECTAL CANCER |
| 2023 | Harmful effect of repetitive intravenous iodinated contrast media administration on the long-term renal function of patients with early gastric cancer
| SCIENTIFIC REPORTS |
| 2015 | Incorporation of radiotherapy in the multidisciplinary treatment of isolated retroperitoneal lymph node recurrence from colorectal cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2017 | Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer | CLINICAL & TRANSLATIONAL ONCOLOGY |
| 2017 | Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer | BRITISH JOURNAL OF SURGERY |
| 2018 | Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2020 | MR prediction of pathologic complete response and early-stage rectal cancer after neoadjuvant chemoradiation in patients with clinical T1/T2 rectal cancer for organ saving strategy
| MEDICINE |
| 2022 | MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy | RADIOLOGY |
| 2016 | MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection
| PLOS ONE |
| 2016 | Multidisciplinary treatment of inferior vena cava leiomyosarcoma. | ANZ JOURNAL OF SURGERY |
| 2020 | Nomogram for prediction of pathologic complete remission using biomarker expression and endoscopic finding after preoperative chemoradiotherapy in rectal cancer
| CHINESE JOURNAL OF CANCER RESEARCH |
| 2012 | Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapy | RADIOTHERAPY AND ONCOLOGY |
| 2009 | Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy | RADIOLOGY |
| 2012 | Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. | EUROPEAN RADIOLOGY |
| 2010 | Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
| 2019 | Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer | RADIOTHERAPY AND ONCOLOGY |
| 2016 | Profiling of rectal cancers MRI in pathological complete remission states after neoadjuvant concurrent chemoradiation therapy | CLINICAL RADIOLOGY |
| 2018 | Prognostic significance of preoperative CT findings in patients with advanced gastric cancer who underwent curative gastrectomy
| PLOS ONE |
| 2012 | Quantitative assessment of tumor responses after radiation therapy in a DLD-1 colon cancer mouse model using serial dynamic contrast-enhanced magnetic resonance imaging
| YONSEI MEDICAL JOURNAL |
| 2017 | Rectal Mucinous Adenocarcinoma: MR Imaging Assessment of Response to Concurrent Chemotherapy and Radiation Therapy-A Hypothesis-generating Study | RADIOLOGY |
| 2016 | Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration | JOURNAL OF SURGICAL ONCOLOGY |
| 2017 | Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid-upper rectal cancer
| JOURNAL OF RADIATION RESEARCH |
| 2021 | Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis
| FRONTIERS IN ONCOLOGY |
| 2018 | T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer | EUROPEAN RADIOLOGY |
| 2014 | The magnetic resonance imaging-based approach for identification of high-risk patients with upper rectal cancer | ANNALS OF SURGERY |
| 2010 | Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2020 | Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
| TRIALS |
